Work

Abstract 1877: Selective inhibitor of nuclear export (SINE) compound, eltanexor (KPT-8602), synergizes with venetoclax (ABT-199) to eliminate leukemia cells and extend survival in an in vivo model of acute myeloid leukemia

Year: 2018

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2018-1877

Authors: Melissa A. Fischer, Pia M. Arrate, Hua Chang, Agnieszka E. Gorska, Londa S. Fuller, Haley E. Ramsey, Trinayan Kashyap, Christian Argueta, William Senapedis, Erkan Baloglu, Yosef Landesman, Sharon Shacham, Michael R. Savona

Institutions: Vanderbilt University Medical Center, Karyopharm Therapeutics (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2887192840

Cites:

Cited by: 1

Related to: 10